BioCentury
ARTICLE | Financial News

Sera Prognostics raises $19.3M in series A

November 16, 2011 1:42 AM UTC

Prenatal diagnostic company Sera Prognostics Inc. (Salt Lake City, Utah) raised $19.3 million in a series A round led by InterWest Partners; Domain Associates; and Catalyst Health Ventures. UpStart Life Sciences Capital and Osage University Partners participated. Sera is developing tests to predict preterm birth, preeclampsia and other pregnancy complications. The Proteomic Assessment of Preterm Risk (PAPR) trial of its preterm birth diagnostic is slated to complete by the end of 2012. Sera plans to launch the diagnostic "shortly thereafter." ...